Arcosa, Inc. (ACA) P/E Ratio History
Historical price-to-earnings valuation from 2018 to 2026
Loading P/E history...
ACA Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 17, 2026, Arcosa, Inc. (ACA) trades at a price-to-earnings ratio of 29.3x, with a stock price of $124.14 and trailing twelve-month earnings per share of $4.52.
The current P/E is roughly in line with its 5-year average of 29.6x. Over the past five years, ACA's P/E has ranged from a low of 10.8x to a high of 50.6x, placing the current valuation at the 50th percentile of its historical range.
Compared to the Industrials sector median P/E of 24.9x, ACA trades at a 18% premium to its sector peers. The sector includes 406 companies with P/E ratios ranging from 0.0x to 172.3x.
The PEG ratio of 2.06 (P/E divided by 122% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, ACA trades roughly in line with the S&P 500 median P/E of 24.5x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ACA DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ACA P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $34B | 29.7 | 2.90 | -42% | |
| $35B | 33.0 | 2.52 | +19% | |
| $69B | 18.7 | 0.60 | +10% | |
| $3B | 11.2 | - | +86% | |
| $253M | 7.3Lowest | - | +135%Best | |
| $1B | 7.5 | 0.22Best | +28% | |
| $11B | 105.0 | 19.32 | -36% | |
| $4B | 21.0 | 6.29 | -15% | |
| $52B | 30.2 | 1.16 | -11% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ACA Historical P/E Data (2018–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $106.14 | $4.06 | 26.1x | -1% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $106.32 | $4.24 | 25.1x | -5% |
| FY2025 Q3 | $93.71 | $3.02 | 31.0x | +17% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $86.71 | $1.88 | 46.1x | +74% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $77.12 | $1.59 | 48.5x | +83% |
| FY2024 Q4 | $96.74 | $1.91 | 50.6x | +91% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $94.76 | $2.62 | 36.2x | +37% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $83.41 | $3.01 | 27.7x | +5% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $85.86 | $2.92 | 29.4x | +11% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $82.64 | $3.26 | 25.3x | -4% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $71.90 | $5.89 | 12.2x | -54% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $75.77 | $5.82 | 13.0x | -51% |
Average P/E for displayed period: 26.5x
See ACA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ACA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ACA vs SPIR
Side-by-side business, growth, and profitability comparison vs Spire Global, Inc..
Start ComparisonACA — Frequently Asked Questions
Quick answers to the most common questions about buying ACA stock.
Is ACA stock overvalued or undervalued?
ACA trades at 29.3x P/E, near its 5-year average of 29.6x. The 50th percentile ranking places valuation within normal historical bounds.
How does ACA's valuation compare to peers?
Arcosa, Inc. P/E of 29.3x compares to sector median of 24.9x. The premium reflects expected growth above peers.
What is ACA's PEG ratio?
ACA PEG ratio is 2.06. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2018-2026.